About
Gencove is a genetic health insights platform leveraging low-pass whole genome sequencing (lpWGS) to give individuals a comprehensive DNA baseline for personalized health decisions. Unlike traditional consumer DNA tests that rely on microarray genotyping — which reads only selected markers — Gencove sequences your entire genome, enabling more accurate Polygenic Risk Scores (PRS) and compatibility with future scientific advances without requiring a retest. The process is straightforward: order an at-home buccal (cheek) swab kit, return it with the included prepaid label, and receive personalized results online. Reports cover 9 predisposition areas across heart and circulation (coronary artery disease, cholesterol, atrial fibrillation), metabolic and kidney health (type 2 diabetes, obesity/BMI, chronic kidney disease), and cancer risk (breast, colorectal, prostate), plus an ancestry module. Each report features at-a-glance High Risk vs. Not High Risk summaries, recommended next steps, trait background, and scientific references to support informed conversations with healthcare providers. Raw sequencing data can be downloaded at any time for personal or clinical use. Gencove is designed as the stable foundation of a broader health stack, meant to be layered alongside periodic lab work, wearables, and lifestyle tracking. A separate enterprise product (enterprise.gencove.com) serves research teams and commercial genomics organizations. Gencove is educational and informational only and is not intended for clinical diagnosis.
Key Features
- Low-Pass Whole Genome Sequencing: Sequences your entire genome rather than reading only selected markers, providing broader and more future-proof results compared to traditional microarray genotyping.
- 9 Predisposition Health Insights: Covers key health areas including coronary artery disease, type 2 diabetes, obesity/BMI, chronic kidney disease, and breast, colorectal, and prostate cancer risk — plus an ancestry module.
- At-Home Collection Kit: Uses a simple buccal (cheek) swab — no blood draw required. Kit ships to your door with a prepaid return label for easy sample submission.
- Raw Data Download: Full access to your complete raw sequencing data at any time, enabling personal record-keeping or use with third-party health and research platforms.
- Actionable Reports with Next Steps: Each result includes a High Risk vs. Not High Risk summary, recommended next steps, and scientific references to support informed conversations with healthcare providers.
Use Cases
- Understanding personal genetic predisposition to common conditions like heart disease, type 2 diabetes, or certain cancers as part of a proactive health strategy.
- Pairing a genetic baseline with wearable device metrics and periodic lab results for increasingly personalized health tracking and lifestyle optimization.
- Downloading raw sequencing data to share with a clinician or integrate with third-party health platforms for deeper clinical-grade analysis.
- Using ancestry information alongside health predisposition data for a comprehensive view of genetic heritage and population-relative health risks.
- Research professionals and enterprise genomics teams accessing scalable whole genome sequencing infrastructure via Gencove's enterprise platform.
Pros
- Affordable Whole Genome Sequencing: At $49, Gencove offers whole genome sequencing at a fraction of typical clinical costs, making comprehensive genetic data accessible to everyday consumers.
- Future-Proof Results: Because the full genome is sequenced, results can be reanalyzed as science evolves — without requiring a new sample or additional purchase.
- Full Raw Data Access: Users can download their complete sequencing data at any time, enabling use with third-party platforms, clinicians, or independent researchers.
- Simple, Non-Invasive Process: The at-home cheek swab requires no blood draw and comes with a prepaid return label for a completely hassle-free submission experience.
Cons
- Educational Use Only: Results are informational and cannot be used for diagnosis, treatment, or medical decision-making without formal clinical follow-up.
- Limited Insight Categories at Launch: Currently covers only 9 health predisposition areas; more traits and insights are described as coming soon, limiting breadth at this stage.
- No Free Tier: Users must pay $49 upfront with no free trial or sample report option to evaluate the platform before purchasing.
Frequently Asked Questions
Is Gencove a diagnostic test?
No. Gencove is educational and informational only. Results should not be used to diagnose, treat, or manage any health condition, and do not replace clinical testing or advice from a qualified healthcare professional.
What is a Polygenic Risk Score (PRS)?
A PRS summarizes the combined effect of many genetic variants — often thousands or millions — across your genome associated with a particular trait. It captures the cumulative influence of common, small-effect variants identified in large genome-wide association studies (GWAS) and places you on a risk spectrum relative to the general population.
How does Gencove differ from traditional DNA tests like 23andMe?
Traditional consumer tests use microarray genotyping, reading only selected DNA markers. Gencove uses low-pass whole genome sequencing to read your entire genome, enabling more accurate risk scores and the ability to reanalyze results as science evolves — without needing a new test or sample.
Can I download my raw genetic data?
Yes. Your complete raw sequencing data is available for download at any time through your Gencove account at no additional cost.
What health areas does Gencove currently cover?
Gencove currently provides predisposition insights for 9 health traits: coronary artery disease, cholesterol, atrial fibrillation, type 2 diabetes, obesity/BMI, chronic kidney disease, breast cancer, colorectal cancer, and prostate cancer — plus an ancestry module. More traits are coming soon.
